New powder spray could stop tumor bleeding during endoscopy
NCT ID NCT07540026
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether spraying two common drugs—tranexamic acid and sucralfate—directly onto bleeding gastrointestinal tumors during an endoscopy can stop the bleeding and prevent it from coming back. Researchers will enroll 60 adults with upper GI tumor bleeding and compare the powder spray plus standard care to standard care alone. The main goals are to see if bleeding stops right away and if it returns within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- tranexamic acid and sucralfate powder
- What this could lead to
- If it works, this could offer a simple, low-cost way to stop bleeding from gastrointestinal tumors during endoscopy and reduce the chance of bleeding again within 30 days.
- What could go wrong
- This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The treatment is added on top of standard care, and its benefit over standard care alone is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients aged ≥ 18 years who accept endoscopy for upper GI tumor bleeding Exclusion Criteria: * patients with no need for endoscopic hemostasis, allergy to sucralfate, tranexamic acid, pregnancy, and patients with hollow organ perforation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bleeding after gi endoscopy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Cheng Kung University Hospital
RECRUITINGTainan, Not Required For This Country, 704, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.